ArticleDrug safety2010
A decade of data mining and still counting.
Article in Drug safety, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches.Frontiers in pharmacology · 2019Pooled it
- Artificial Intelligence: Applications in Pharmacovigilance Signal Management.Pharmaceutical medicine · 2025Review
- Article
- Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.Therapeutic advances in drug safety · 2019Article
- The hope, hype and reality of Big Data for pharmacovigilance.Therapeutic advances in drug safety · 2018Article
- vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real-world use.Pharmacoepidemiology and drug safety · 2017Article
- The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies.Therapeutic advances in drug safety · 2017Article
- Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance.Therapeutic advances in drug safety · 2016Article
- Good Signal Detection Practices: Evidence from IMI PROTECT.Drug safety · 2016Article
- Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).Drug safety · 2016Article
- A Multiagent System for Integrated Detection of Pharmacovigilance Signals.Journal of medical systems · 2016Article
- Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworks.Drug safety · 2015Article
- Article
- Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection.BMC bioinformatics · 2014Article
- Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition.International journal of medical sciences · 2013Article
- Signal detection and monitoring based on longitudinal healthcare data.Pharmaceutics · 2012Article
- Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.Drug safety · 2011Article
- An experimental investigation of masking in the US FDA adverse event reporting system database.Drug safety · 2010Article
- Using information mining of the medical literature to improve drug safety.Journal of the American Medical Informatics Association : JAMIAArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
20553054What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.